Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Intercept Pharmaceuticals Company Profile (NASDAQ:ICPT)

Consensus Ratings for Intercept Pharmaceuticals (NASDAQ:ICPT) (?)
Ratings Breakdown: 1 Sell Rating(s), 6 Hold Rating(s), 13 Buy Rating(s)
Consensus Rating:Buy (Score: 2.60)
Consensus Price Target: $373.88 (43.00% upside)

Current Analysts' Coverage Summary for Intercept Pharmaceuticals (NASDAQ:ICPT)
Show:
DateFirmActionRatingPrice TargetActions
5/21/2015BarclaysInitiated CoverageOverweight$425.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/20/2015WedbushReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/19/2015BMO Capital MarketsSet Price TargetBuy$515.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/19/2015Bank of AmericaDowngradeBuy -> Neutral$315.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/12/2015RBC CapitalSet Price TargetPositive -> Buy$490.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/11/2015Needham & Company LLCReiterated RatingBuy$500.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/11/2015Janney Montgomery ScottBoost Price TargetBuy$350.00 -> $363.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/1/2015ZacksReiterated RatingHold -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/27/2015MLV & Co.Set Price TargetHold$273.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/27/2015Deutsche BankBoost Price TargetBuy$300.00 -> $400.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/23/2015Leerink SwannBoost Price TargetMarket Perform$205.00 -> $265.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/20/2015NomuraSet Price TargetBuy$440.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/18/2015Robert W. BairdBoost Price TargetBuy$258.00 -> $344.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/28/2015OppenheimerLower Price TargetOutperform$499.00 -> $375.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/15/2015Cowen and CompanySet Price TargetBuy$420.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/18/2014Sterne Agee CRTInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/3/2014FBR & Co.Lower Price TargetUnderperform$125.00 -> $99.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/4/2014Summer StreetReiterated RatingPositiveView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/14/2014TheStreetUpgradeHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/2/2014Goldman SachsInitiated CoverageNeutral$265.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/10/2014Citigroup Inc.Reiterated RatingBuy$60.00 -> $400.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/22/2013 forward)